Bryan Liu

Mutungamiriri weDhipatimendi rePasi Pose, TianJin Cancer Hospital Airport Hospital

Nhengo yeKomiti yeMaitiro kuTianJin Cancer Hospital Airport Hospital

Muvambi weBioocus Medical Group & CGT Centers

Purofesa weSainzi Research Management paChikoro cheLife Sciences, Beijing Institute of Technology

Mutungamiriri weBoka Rinoshanda reBato reKomiti yeNyanzvi dzeCellular Immunotherapy kuChina Association for the Promotion of Human Health Technology

Nyanzvi mukurapa nemakemikari, kurapwa kwakanangana, kurapwa neCAR-T, uye immunotherapy yezvirwere zveropa.

Ruzivo rwakakura mukurapa nezvirwere zveropa zvisina kunaka zvakaita sereaktory and recurred leukemia, lymphoma, uye multiple myeloma, vane hunyanzvi mukurapa nyaya dzakaoma uye dzinonetsa.

Akabudirira zvikuru mukurapa varwere vanodzoka vachishandisa masero ekudzivirira chirwere kuvarwere vekune dzimwe nyika, zvichiratidza kubudirira kukuru pakurapa.

Anoshanda semupi wezano wekurapa zvirwere zvemuviri kuApollo Hospitals muIndia, achikurudzira kushanda pamwe chete kwekurapa pakati penyika dzakasiyana.

Anopfuura makore gumi eruzivo rwekiriniki mukuongorora nekurapa zvirwere zvakaoma zveropa.

Ndakatora chikamu muzviitiko zvinopfuura mazana matatu zvekurapa masero ekudzivirira muviri kune varwere vekunze kwenyika, kusanganisira zviitiko zve recurrent leukemia, lymphoma, Neuroblastoma, multiple myeloma, MG, SLE, SSC, Thalassemia, SCD, TDT.

Ndakazvipira pakurapa masero emuviri uye kurapwa kwemajini kwemakore makumi maviri.

Zvakawana mhedzisiro yakakosha mukurapa neCAR-T, kurapwa neTILs, kurapwa neNK, uye kurapwa nemajini.

Vakavamba nzvimbo ina dzeCellular neGene therapy (CGT therapy centers) muBeijing neTianjin.